Bernstein SocGen Group analyst Lance Wilkes upgraded CVS Health (NYSE: CVS) from Market Perform to Outperform with a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Upgrades